Literature DB >> 18951967

Molecular pharmacological basis of the YiSui ShenXu Granule in beta-thalassemia therapy.

Chong Zhang1, Zhi-Kui Wu.   

Abstract

OBJECTIVES: To study the molecular pharmacological basis of the YiSui ShenXu Granule, a complex prescription of the Chinese traditional medicine used to treat beta-thalassemia.
METHODS: Real-time quantitative PCR method had been applied to analyze the genes expression: gamma-globin, Ckit, EpoR, Spi, FKLF, GATA1 and GATA2 in K562 cell treated and untreated with this complex prescription and its each single herbal medicine.
RESULTS: The results showed that this complex prescription increased the gamma-globin, EpoR, Spi and FKLF expression and decreased the Ckit, GATA1 and GATA2 expression. And all single herbal medicines of this complex prescription could change some of those gene expressions, but not the same as the complex prescription. Even that, this study results indicated that the YiSui ShenXu Granule has its molecular pharmacological basis in treating beta-thalassemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18951967     DOI: 10.1016/j.jep.2008.09.024

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

1.  Emodin can induce K562 cells to erythroid differentiation and improve the expression of globin genes.

Authors:  Yan-Ni Ma; Ming-Tai Chen; Zhi-Kui Wu; Hua-Lu Zhao; Hai-Chuan Yu; Jia Yu; Jun-Wu Zhang
Journal:  Mol Cell Biochem       Date:  2013-06-07       Impact factor: 3.396

2.  α:Non-α and Gγ:Aγ globin chain ratios in thalassemia intermedia patients treated with hydroxyurea.

Authors:  Abbas Najjari; Mohsen Asouri; Ladan Hosseini Gouhari; Haleh Akhavan Niaki; Amir Sasan Mozaffari Nejad; Seyyedeh Masoumeh Eslami; Hassan Abolghasemi; Ramin Ataee; Abdol Ali Ebrahimi; Masoumeh Rezaei Moshaei; Ali Asghar Ahmadi
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

3.  Effect of Chinese Herbal Medicine Therapy on Risks of Overall, Diabetes-Related, and Cardiovascular Diseases-Related Mortalities in Taiwanese Patients With Hereditary Hemolytic Anemias.

Authors:  Mu-Lin Chiu; Jian-Shiun Chiou; Chao-Jung Chen; Wen-Miin Liang; Fuu-Jen Tsai; Yang-Chang Wu; Ting-Hsu Lin; Chiu-Chu Liao; Shao-Mei Huang; Chen-Hsing Chou; Cheng-Wen Lin; Te-Mao Li; Yu-Lung Hsu; Ying-Ju Lin
Journal:  Front Pharmacol       Date:  2022-05-30       Impact factor: 5.988

Review 4.  Natural Remedies for the Treatment of Beta-Thalassemia and Sickle Cell Anemia-Current Status and Perspectives in Fetal Hemoglobin Reactivation.

Authors:  Noel Yat Hey Ng; Chun Hay Ko
Journal:  Int Sch Res Notices       Date:  2014-10-02

Review 5.  Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β-Thalassemia.

Authors:  Nur Atikah Zakaria; Md Asiful Islam; Wan Zaidah Abdullah; Rosnah Bahar; Abdul Aziz Mohamed Yusoff; Ridhwan Abdul Wahab; Shaharum Shamsuddin; Muhammad Farid Johan
Journal:  Biomolecules       Date:  2021-05-18

6.  Clinical Effect and Mechanism of Yisui Shengxue Granules in Thalassemia Patients with Mild, Moderate, or Severe Anemia.

Authors:  Yan-Ling Cheng; Xin-Hua Zhang; Yu-Wen Sun; Wen-Juan Wang; Su-Ping Fang; Zhi-Kui Wu
Journal:  Evid Based Complement Alternat Med       Date:  2016-02-02       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.